journal article·2018-10-31

Recent progress in synergistic chemotherapy and phototherapy by targeted drug delivery systems for cancer treatment

Jie Cao, Zuxian Chen, Jinnan Chi, Yalin Sun, Yong Sun

Publisher page

Abstract

Although it's pharmacological effect for cancer therapy, conventional chemotherapy has been compromised by a series of shortcomings such as limited stability, nonspecific tumour targeting ability and severe toxic side effects. To overcome these limitations, multifunctional targeted drug delivery systems for combinatorial therapeutics have been widely explored as novel cancer therapy strategies, showing encouraging results in many pre-clinical animal experiments. Among them, synergistic phototherapy and chemotherapy have demonstrated their abilities to enhance therapeutic efficacies and reduce unwanted side effects via a variety of mechanisms. In this review, we will summarize the latest progress in the development of targeted drug delivery systems with combinations of phototherapy and chemotherapy and discuss the important roles of phototherapy agents involved in those non-conventional therapeutic strategies.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Luminescence and Fluorescent Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutics, School of Pharmacy, Qingdao University

Funding

National Natural Science Foundation of China · Shandong Provincial Natural Science Foundation · China Postdoctoral Natural Science Foundation

References (54)

Show source-provided references
1. 10.1158/1078-0432.CCR-16-210210.1158/1078-0432.CCR-16-2102 ↗
2. 10.3109/21691401.2013.85317910.3109/21691401.2013.853179 ↗
3. 10.1021/nn401168610.1021/nn4011686 ↗
4. 10.1038/nrc107110.1038/nrc1071 ↗
5. 10.1016/j.biomaterials.2016.05.00110.1016/j.biomaterials.2016.05.001 ↗
6. 10.1021/bm400839b10.1021/bm400839b ↗
7. 10.1166/jnn.2014.875710.1166/jnn.2014.8757 ↗
8. Kanapathipillai M, Brock A, Ingber DE. Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment. Adv Drug Deliv Rev. 2016;26:107–118.
9. 10.1016/j.progpolymsci.2013.07.00510.1016/j.progpolymsci.2013.07.005 ↗
10. 10.1016/j.addr.2015.01.00210.1016/j.addr.2015.01.002 ↗
11. 10.1080/21691401.2017.139700110.1080/21691401.2017.1397001 ↗
12. 10.3322/caac.2011410.3322/caac.20114 ↗
13. 10.1039/C2CS35216H10.1039/C2CS35216H ↗
14. 10.1016/j.jconrel.2008.10.01010.1016/j.jconrel.2008.10.010 ↗
15. 10.1002/ange.20110355710.1002/ange.201103557 ↗
16. Fan L, Zhao SS, Jin X, et al. Synergistic chemo-photodynamic therapy by “big & small combo nanoparticles” sequential release system. Nanomedicine. 2017;14:109–121.
17. 10.1039/C5NR06305A10.1039/C5NR06305A ↗
18. 10.1021/acsami.6b0444210.1021/acsami.6b04442 ↗
19. 10.1002/smll.20110066910.1002/smll.201100669 ↗
20. 10.1039/c2cs15229k10.1039/c2cs15229k ↗
21. 10.3109/21691401.2015.100851110.3109/21691401.2015.1008511 ↗
22. 10.1021/acsami.6b1444610.1021/acsami.6b14446 ↗
23. 10.1038/s41467-017-01050-010.1038/s41467-017-01050-0 ↗
24. 10.1021/acsami.6b1180310.1021/acsami.6b11803 ↗
25. 10.1002/anie.20140218910.1002/anie.201402189 ↗
26. 10.7150/thno.1410110.7150/thno.14101 ↗
27. 10.1021/acs.inorgchem.7b0038010.1021/acs.inorgchem.7b00380 ↗
28. 10.1021/acsnano.6b0752510.1021/acsnano.6b07525 ↗
29. 10.1016/j.biomaterials.2017.09.01110.1016/j.biomaterials.2017.09.011 ↗
30. 10.1016/j.biomaterials.2017.06.03110.1016/j.biomaterials.2017.06.031 ↗
31. 10.1007/s12274-017-1858-y10.1007/s12274-017-1858-y ↗
32. 10.1021/acsami.7b0092710.1021/acsami.7b00927 ↗
33. 10.1021/acsami.5b0116510.1021/acsami.5b01165 ↗
34. 10.1039/C4CS00163J10.1039/C4CS00163J ↗
35. 10.1038/nbt.154910.1038/nbt.1549 ↗
36. 10.1021/acsnano.6b0542710.1021/acsnano.6b05427 ↗
37. 10.1016/j.biomaterials.2015.09.01810.1016/j.biomaterials.2015.09.018 ↗
38. Song X, Chen Q, Liu Z. Recent advances in the development of organic photothermal nano-agents. Nano Res. 2014;8:340–354.
39. 10.1016/0024-3205(68)90108-210.1016/0024-3205(68)90108-2 ↗
40. 10.1016/j.actbio.2016.12.00410.1016/j.actbio.2016.12.004 ↗
41. 10.1021/acsami.7b0804710.1021/acsami.7b08047 ↗
42. 10.1002/adma.20140430810.1002/adma.201404308 ↗
43. 10.1016/j.biomaterials.2013.05.00810.1016/j.biomaterials.2013.05.008 ↗
44. 10.18632/oncotarget.1032010.18632/oncotarget.10320 ↗
45. 10.1021/acsnano.5b0509710.1021/acsnano.5b05097 ↗
46. 10.1016/j.biomaterials.2013.01.05110.1016/j.biomaterials.2013.01.051 ↗
47. 10.1021/am507658v10.1021/am507658v ↗
48. 10.1002/smll.20160274710.1002/smll.201602747 ↗
49. 10.1002/adfm.20140307910.1002/adfm.201403079 ↗
50. 10.1021/nn900215k10.1021/nn900215k ↗
51. 10.1016/j.actbio.2017.01.01510.1016/j.actbio.2017.01.015 ↗
52. 10.1002/adfm.20130155510.1002/adfm.201301555 ↗
53. 10.1016/j.actbio.2016.11.03510.1016/j.actbio.2016.11.035 ↗
54. 10.1002/adfm.20170541610.1002/adfm.201705416 ↗